Effect of eslicarbazepine acetate (BIA 2-093) on latrunculin A-induced seizures and extracellular amino acid concentrations in the rat hippocampus

Epilepsy Research

Volumn 77, Issue 1, 2007, Pages 36-43

  Sierra Paredes, Germán ^a   Oreiro García, Ma Teresa ^a   Vázquez Illanes, Ma Dolores ^a   Sierra Marcuño, Germán ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Amino acids; BIA 2 093; Eslicarbazepine acetate; Latrunculin A; Microdialysis; Seizures

Indexed keywords

10 ACETOXY 10,11 DIHYDRO 5H DIBENZ[B,F]AZEPINE 5 CARBOXAMIDE; 6 AMINOQUINOLYL N HYDROXYSUCCINIMIDYLCARBAMATE; AMINO ACID; ASPARTIC ACID; CARBAMAZEPINE; CARBAMIC ACID DERIVATIVE; ESLICARBAZEPINE ACETATE; GLUTAMIC ACID; GLYCINE; LATRUNCULIN A; LICARBAZEPINE; OXCARBAZEPINE; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PERFUSION; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAM; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; VIDEORECORDING;

AMINO ACIDS; ANIMALS; ANTICONVULSANTS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIBENZAZEPINES; ELECTROENCEPHALOGRAPHY; EXTRACELLULAR SPACE; HIPPOCAMPUS; INDICATORS AND REAGENTS; MALE; MARINE TOXINS; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; THIAZOLIDINES;

EID: 35348847663     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.08.006     Document Type: Article

References (56)

1. Ahmad S., Fowler L.J., and Whitton P.S. Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats. Brain Res. 1029 (2004) 41-47
2. Ahmad S., Fowler L.J., and Whitton P.S. Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids. Epilepsy Res. 63 (2005) 141-149
3. Allison D.W., Gelfand V.I., Spector I., and Craig A.M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18 (1998) 2423-2436
4. Almeida L., and Soares-da-Silva P. Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. J. Clin. Pharmacol. 5 (2004) 906-918
5. Ambrósio A.F., Silva A.P., Malva J.O., Soares-da-Silva P., Carvalho A.P., and Carvalho C.M. Inhibition of glutamate release by BIA 2-093 and BIA 2-024, two novel derivatives of carbamazepine, due to blockade of sodium but not calcium channels. Biochem. Pharm. 61 (2001) 1271-1275
6. Ambrósio A.F., Soares-da-Silva P., Carvalho C.M., and Carvalho A.P. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem. Res. 27 (2002) 121-130
7. Baker D.A., Xi Z.X., Shen H., Swanson C.J., and Kalivas P.W. The origin and neuronal function of in vivo nonsynaptic glutamate. J. Neurosci. 22 (2002) 9134-9141
8. Benes J., Parada A., Figueiredo A.A., Alves P.C., Freitas A.P., Learmonth D.A., Cunha R.A., Garret J., and Soares-Da-Silva P. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J. Med. Chem. 42 (1999) 2582-2587
9. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Perucca E., and Tomson T. Progress report on new anti epileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII). Epilepsy Res. 61 (2004) 1-48
10. Bianchi M.G., Rotoli B.M., Dall'Asta V., Gazzola G.C., Gatti R., and Bussolati O. PKC-dependent stimulation of EAAT3 glutamate transporter does not require the integrity of actin cytoskeleton. Neurochem. Int. 48 (2006) 341-349
11. Bonifácio M.J., Sheridan R.D., Parada A., Cunha R.A., Patmore L., and Soares-Da-Silva P. Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine. Epilepsia 42 (2001) 600-608
12. Bradford H.F. Glutamate, GABA and epilepsy. Prog. Neurobiol. 47 (1995) 477-511
13. Bradford S.E., and Nadler J.V. Aspartate release from rat hippocampal synaptosomes. Neuroscience 128 (2004) 751-765
14. Chapman A.G. Glutamate receptors in epilepsy. Prog. Brain Res. 116 (1998) 371-383
15. Chapman A.G. Glutamate and epilepsy. J. Nutr. 130 4S (2000) 1043S-1045S
16. Clinckers R., Gheuens S., Smolders I., Meurs A., Ebinger G., and Michotte Y. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin. Epilepsia 46 (2005) 828-836
17. Cunha R.A., Coelho J.E., Costenla A.R., Lopes L.V., Parada A., De Mendonça A., Sebastião A.M., and Ribeiro J.A. Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices. Pharmacol. Toxicol. 90 (2002) 208-213
18. During M.J., and Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341 (1993) 1607-1610
19. Hainzl D., Parada A., and Soares-Da-Silva P. Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res. 44 (2001) 197-206
20. Halpain S., Hipolito A., and Saffer L. Regulation of F-actin stability in dendritic spines by glutamate receptors and calcineurin. J. Neurosci. 18 (1998) 9835-9844
21. Hertz L., and Zielke H.R. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27 (2004) 735-743
22. Houssen W.E., Jaspers M., Wease K.N., and Scott R.H. Acute actions of marine toxin latrunculin A on the electrophysiological properties of cultured dorsal root ganglion neurones. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 142 (2006) 19-29
23. Loiseau P., and Duché P. Carbamazepine. Clinical use. In: Levy R.H., Mattson R.H., and Meldrum B.S. (Eds). Antiepileptic drugs (1995), Raven Press, New York 555-566
24. Maia J., Almeida L., and Soares-da-Silva P. BIA 2-093 as add-on therapy for refractory partial epilepsy in adults. Epilepsia 45 3 (2004) 158
25. Miece M., Boutelle M.G., and Fillenz M. The source of physiologically stimulated glutamate efflux from the striatum of conscious rats. J. Physiol. (Lond.) 497 (1996) 745-751
26. Morales M., Colicos M.A., and Goda Y. Actin-dependent regulation of neurotransmitter release at central synapses. Neuron 27 (2000) 539-550
27. Nyitrai G., Kékesi K.A., and Juhász G. Extracellular level of GABA and Glu: in vivo microdialysis-HPLC measurements. Curr. Top. Med. Chem. 6 (2006) 935-940
28. Obrenovitch T.P., Urenjak J., and Zilkha E. Evidence disputing the link between seizure activity and high extracellular glutamate. J. Neurochem. 66 (1996) 2446-2454
29. Obrenovitch T.P., Urenjak J., and Zilkha E. Effects of increased extracellular glutamate levels on the local field potential in the brain of anaesthetized rats. Br. J. Pharmacol. 122 (1997) 372-378
30. Oreiro-García M.T., Vázquez-Illanes M.D., Sierra-Paredes G., and Sierra-Marcuño G. Changes in extracellular amino acid concentrations in the rat hippocampus after in vivo actin depolymerization with latrunculin A. Neurochem. Int. 50 (2007) 734-740
31. Oreiro-García M.T., Vázquez-Illanes M.D., Sierra-Paredes G., and Sierra-Marcuño G. Neuroactive amino acids determination using a modification of 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate method. Biomed. Chrom. 19 (2005) 720-724
32. Parada A., and Soares-da-Silva P. The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine. Neurochem. Int. 40 (2002) 435-440
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, London
34. Petroff O.A., Rothman D.L., Behar K.L., Hyder F., and Mattson R.H. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 8 (1999) 120-127
35. Ramsay R.E., Wilder B.J., Berger J.R., and Bruni J.A. Double-blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults. Neurology 33 (1983) 904-910
36. Rogawski M.A. Diverse mechanisms of antiepileptic drugs in the development pipeline. Epilepsy Res. 69 (2006) 273-294
37. Rowley H.L., Marsden C.A., and Martin K.F. Differential effects of phenytoin and sodium valproate on seizure-induced changes in gamma-aminobutyric acid and glutamate release in vivo. Eur. J. Pharmacol. 294 (1995) 541-546
38. Sattler R., Xiong Z., Lu W.Y., MacDonald J.F., and Tymianski M. Distinct roles of synaptic and extrasynaptic NMDA receptors in excitotoxicity. J. Neurosci. 20 (2000) 22-33
39. Sherwin A.L. Neuroactive amino acids in focally epileptic human brain: a review. Neurochem. Res. 24 (1999) 1387-1395
40. Scheyer R.D. Involvement of glutamate in human epileptic activities. Prog. Brain Res. 116 (1998) 359-369
41. Schousboe A., Sarup A., Bak L.K., Waagepetersen H.S., and Larsson O.M. Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem. Int. 45 (2004) 521-527
42. Sierra-Paredes G., Galán-Valiente J., Vazquez-Illanes M.D., Aguilar-Veiga E., Soto-Otero R., Méndez-Alvarez E., and Sierra-Marcuño G. Extracellular amino acids in the rat hippocampus during picrotoxin threshold seizures in chronic microdialysis experiments. Neurosci. Lett. 248 (1998) 53-56
43. Sierra-Paredes G., Galán-Valiente J., Vazquez-Illanes M.D., Aguilar-Veiga E., and Sierra-Marcuño G. Effect of ionotropic glutamate receptors antagonists on the modifications in extracellular glutamate and aspartate levels during picrotoxin seizures: a microdialysis study in freely moving rats. Neurochem. Int. 37 (2000) 377-386
44. Sierra-Paredes G., Senra-Vidal A., and Sierra-Marcuño G. Effect of extracellular high concentrations of glutamate and glycine on picrotoxin seizure thresholds: a microdialysis study in freely moving rats. Brain Res. 888 (2001) 19-25
45. Sierra-Paredes G., Núñez-Rodríguez A., Vázquez-López A., Oreiro-García M.T., and Sierra-Marcuño G. Anticonvulsant effect of Eslicarbazepine Acetate (BIA 2-093) on seizures induced by microperfusion of picrotoxin in the hippocampus of freely moving rats. Epilepsy Res. 72 (2006) 140-146
46. Sierra-Paredes G., Oreiro-García M.T., Núñez-Rodríguez A., Vázquez-López A., and Sierra-Marcuño G. Seizures induced by in vivo latrunculin A and jasplakinolide microperfusion in the rat hippocampus. J. Mol. Neurosci. 28 (2006) 151-160
47. Smolders I., Van Belle K., Ebinger G., and Michotte Y. Hippocampal and cerebellar extracellular amino acids during pilocarpine-induced seizures in freely moving rats. Eur. J. Pharmacol. 319 (1997) 21-29
48. Spector I., Shochet N.R., Kashman Y., and Groweiss A. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 219 (1983) 493-495
49. Spector I., Shochet N.R., Blasberger D., and Kashman Y. Latrunculins-novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. Cell Motil. Cytoskeleton 13 (1989) 127-144
50. Spina E. Carbamazepine: chemistry, biotransformation, and pharmacokinetics. In: Levy R.H., Mattson R.H., Meldrum M.S., and Perucca E. (Eds). Antiepileptic Drugs (2002), Lippincott Williams & Wilkins, Philadelphia 236-246
51. Timmerman W., and Westerink B.H. Brain microdialysis of GABA and glutamate: what does it signify?. Synapse 27 (1997) 242-261
52. Vázquez-López A., Sierra-Paredes G., and Sierra-Marcuño G. Seizures induced by microperfusion of glutamate and glycine in the hippocampus of rats pretreated with latrunculin A. Neurosci. Lett. 388 (2005) 81-85
53. Waldmeier P.C., Baumann P.A., Wicki P., Feldtrauer J.J., Stierlin C., and Schmutz M. Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45 (1995) 1907-1913
54. Waldmeier .P.C., Martin P., Stocklin K., Portet C., and Schmutz M. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn Schmiedebergs Arch. Pharmacol. 354 (1996) 164-172
55. Wang S.J., Sihra T.S., and Gean P.W. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 12 (2001) 2255-2258
56. Zhou J., and Sutherland M.L. Glutamate transporter cluster formation in astrocytic processes regulate glutamate uptake activity. J. Neurosci. 24 (2004) 6301-6306